HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

  • J1813

    Insulin (lyumjev) for administration through dme (i.e., insulin pump) per 50 units

  • J1814

    Insulin (lyumjev), per 5 units

  • J1815

    Injection, insulin, per 5 units

  • J1817

    Insulin for administration through dme (i.e., insulin pump) per 50 units

  • J1823

    Injection, inebilizumab-cdon, 1 mg

  • J1826

    Injection, interferon beta-1a, 30 mcg

  • J1830

    Injection, interferon beta-1b, 0.25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

  • J1833

    Injection, isavuconazonium, 1 mg

  • J1834

    Injection, isoniazid, 1 mg

  • J1835

    Injection, itraconazole, 50 mg

  • J1836

    Injection, metronidazole, 10 mg

  • J1837

    Injection, posaconazole, 1 mg

  • J1840

    Injection, kanamycin sulfate, up to 500 mg

  • J1850

    Injection, kanamycin sulfate, up to 75 mg

  • J1885

    Injection, ketorolac tromethamine, per 15 mg

  • J1890

    Injection, cephalothin sodium, up to 1 gram

  • J1920

    Injection, labetalol hydrochloride, 5 mg

  • J1921

    Injection, labetalol hydrochloride (hikma), not therapeutically equivalent to j1920, 5 mg

  • J1930

    Injection, lanreotide, 1 mg

  • J1931

    Injection, laronidase, 0.1 mg

  • J1932

    Injection, lanreotide, (cipla), 1 mg

  • J1938

    Injection, furosemide, 1 mg

  • J1939

    Injection, bumetanide, 0.5 mg

  • J1940

    Injection, furosemide, up to 20 mg

  • J1941

    Injection, furosemide (furoscix), 20 mg

  • J1942

    Injection, aripiprazole lauroxil, 1 mg

  • J1943

    Injection, aripiprazole lauroxil, (aristada initio), 1 mg

  • J1944

    Injection, aripiprazole lauroxil, (aristada), 1 mg

  • J1945

    Injection, lepirudin, 50 mg

  • J1950

    Injection, leuprolide acetate (for depot suspension), per 3.75 mg

  • J1951

    Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg

  • J1952

    Leuprolide injectable, camcevi, 1 mg

  • J1953

    Injection, levetiracetam, 10 mg

  • J1954

    Injection, leuprolide acetate for depot suspension (lutrate depot), 7.5 mg

  • J1955

    Injection, levocarnitine, per 1 gm

  • J1956

    Injection, levofloxacin, 250 mg

  • J1960

    Injection, levorphanol tartrate, up to 2 mg

  • J1961

    Injection, lenacapavir (only for use as hiv treatment), 1 mg

  • J1980

    Injection, hyoscyamine sulfate, up to 0.25 mg

  • J1990

    Injection, chlordiazepoxide hcl, up to 100 mg

  • J2001

    Injection, lidocaine hcl for intravenous infusion, 10 mg

  • J2002

    Injection, lidocaine hcl in 5% dextrose, 1 mg

  • J2003

    Injection, lidocaine hydrochloride, 1 mg

  • J2004

    Injection, lidocaine hcl with epinephrine, 1 mg

  • J2010

    Injection, lincomycin hcl, up to 300 mg

  • J2020

    Injection, linezolid, 200 mg

  • J2021

    Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg

  • J2060

    Injection, lorazepam, 2 mg

  • J2062

    Loxapine for inhalation, 1 mg

  • J2150

    Injection, mannitol, 25% in 50 ml

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.